Characteristics of atrial substrates for atrial tachyarrhythmias induced in aged and hypercholesterolemic rabbits

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 5, 2012, Pages 544-552

  Lee, Kun Tai ^a,b   Hsieh, Chang Chao ^b   Tsai, Wei Chung ^b   Tang, Paul Wei Hua ^b   Liu, I Hsin ^b   Chai, Chee Yin ^a,b   Sheu, Sheng Hsiung ^a,b   Lai, Wen Ter ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

aged; atrial substrates; atrial tachyarrhymias; hypercholesterolemia

Indexed keywords

CHOLESTEROL; CONNEXIN 40; CONNEXIN 43; STRESS ACTIVATED PROTEIN KINASE;

AGING; ARTICLE; CHOLESTEROL DIET; ENZYME PHOSPHORYLATION; GAP JUNCTION; HEART MUSCLE FIBROSIS; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; RABBIT; SUPRAVENTRICULAR TACHYCARDIA;

AGING; ANIMALS; ATRIAL FIBRILLATION; HEART ATRIA; HEART CONDUCTION SYSTEM; HYPERCHOLESTEROLEMIA; MALE; RABBITS;

EID: 84862793517     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03355.x     Document Type: Article

References (31)

1. Kannel WB, Wolf PA, Benjamin EJ, Levy D,. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. Am J Cardiol 1998; 82: 2N-9N.
2. Kourliouros A, Savelieva I, Kiotsekoglou A, Jahangiri M, Camm J,. Current concepts in the pathogenesis of atrial fibrillation. Am Heart J 2009; 157: 243-252.
3. Schoonderwoerd BA, Van Gelder IC, Van Veldhuisen DJ, Van den Berg MP, Crijns HJ,. Electrical and structural remodeling: Role in the genesis and maintenance of atrial fibrillation. Prog Cardiovas Dis 2005; 48: 153-168.
4. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, et al,. Worldwide survey on the methods, efficiency, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111: 1100-1115.
5. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, et al,. Updated worldwide survey on the methods, efficiency, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 32-38.
6. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA,. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 33-36.
7. Iguchi Y, Kimura K, Aoki J, Kobayashi K, Terasawa Y, Sakai K, Shibazaki K,. Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: Analysis of 41436 nonemployee residents in Kurashiki-city. Circ J 2008; 72: 909-913.
8. Liu YB, Wu CC, Lu LS, Su MJ, Lin CW, Lin SF, Lee YT,. Sympathetic nerve sprouting, electrical remodeling, and increased vulnerability to ventricular fibrillation in hypercholesterolemic rabbits. Circ Res 2003; 92: 1145-1152.
9. Kato T, Yamashita T, Sekiguchi A, Sagara K, Takamura M, Takata S, Kaneko S, et al,. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol 2006; 17: 890-894.
10. Lee HC, Sheu SH, Yeh HW, Lai WT, Chang JG,. JNK/ATF2 pathway is involved in iodinated contrsast media-induced apoptosis. Am J Nephrol 2010; 31: 125-133.
11. Chaldoupi SM, Loh P, Hauer RN, de Bakker JM, van Rijen HV,. The role of connexin 40 in atrial fibrillation. Cardiovasc Res 2009; 84: 15-23.
12. van Veen AA, van Rijen HV, Opthof T,. Cardiac gap junction channels: Modulation of expression and channel properties. Cardiovasc Res 2001; 51: 217-229.
13. Severs NJ, Coppen SR, Dupont E, Yeh HI, Ko YS, Matsushita T,. Gap junction alterations in human cardiac disease. Cardiovasc Res 2004; 62: 368-377.
14. Thomas SA, Schuessler RB, Berul CI, Beardslee MA, Beyer EC, Mendelsohn ME, Saffitz JE,. Disparate effects of deficient expression of connexin 43 on atrial and ventricular conduction: Evidence for chamber-specific molecular determinants of conduction. Circulation 1998; 97: 686-691.
15. Eckardt D, Theis M, Degen J, Ott T, van Rijen HV, Kirchhoff S, Kim JS, et al,. Functional role of connexin 43 gap junction channels in adult mouse heart assessed by inducible gene delection. J Mol Cell Cardiol 2004; 36: 101-110.
16. Thomas SA, Schuessler RB, Saffitz JE,. Connexins, conduction, and atrial fibrillation. J Cardiovasc Electrophysiol 1998; 9: 608-611.
17. Kanagaratnam P, Rothery S, Patel P, Severs NJ, Peters NS,. Relative expression of immunolocalized connexin 40 and 43 correlates with human atrial conduction properties. J Am Coll Cardiol 2002; 39: 116-123.
18. van der Velden HM, Ausma J, Rook MB, Hellemons AJ, van Veen TA, Allessie MA, Jongsma HJ,. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 2000; 46: 476-486.
19. Hagendorff A, Schumacher B, Kirchhoff S, Luderitz B, Willecke K,. Conduction disturbances and increased atrial vulnerability in connexin 40 deficient mice analyzed by transesophageal stimulation. Circulation 1999; 99: 1508-1515.
20. Kirchoff S, Nelles E, Hagendorff A, Kruger O, Traub O, Willecke K,. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin 40-deficient mice. Curr Biol 1998; 8: 299-302.
21. Bagwe S, Berenfeld O, Vaidya D, Morley GE, Jalife J,. Altered right atrial excitation and propagation in connexin 40 knockout mice. Circulation 2005; 112: 2245-2253.
22. Meyer RA, Lampe PD, Malewicz B, Baumann WJ, Johnson RG,. Enhanced gap junction formation with LDL and apolipoprotein B. Exp Cell Res 1991; 196: 72-78.
23. Henry PD, Pacifico A,. Altering molecular mechanisms to prevent sudden arrhythmic death. Lancet 1998; 351: 1276-1278.
24. Petrich BG, Gong X, Lerner DL, Wang X, Brown JH, Saffitz JE, Wang Y,. c-Jun N-terminal kinase activation mediates downregulation of connexin 43 in cardiomyocytes. Circ Res 2002; 91: 640-647.
25. Lin LC, Wu CC, Yeh HI, Lu LS, Liu YB, Lin SF, Lee YT,. Downregulated myocardial connexin 43 and suppressed contractility in rabbits subjected to a cholesterol-enriched diet. Lab Invest 2005; 85: 239-244.
26. Wang YP, Choe M, Choi SY, Jin U, Kim CK, Seo EJ, Cho IJ, et al,. Increased expression of connexin43 on the aortic valve in the hypercholesterolemic rabbit model. J Invest Surg 2009; 22: 98-104.
27. Polacek D, Bech F, McKinsey JF, Davies PF,. Connexin43 gene expression in the rabbit arterial wall: effects of hypercholesterolemia, balloon injury and their combination. J Vasc Res 1997; 34: 19-30.
28. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A,. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-1184.
29. Yang SS, Han W, Zhou HY, Dong G, Wang BC, Huo H, Wei N, et al,. Effectives of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs. Chin Med J (Engl) 2008; 121: 38-42.
30. Pellman J, Lyon RC, Sheikh F,. Extracellular matrix remodeling in atrial fibrosis: Mechanisms and implications in atrial fibrillation. J Mol Cell Cardiol 2010; 48: 461-467.
31. Hayashi H, Wang C, Miyauchi Y, Omichi C, Pak HN, Zhou S, Ohara T, et al,. Aging-related increase to inducible atrial fibrillation in the rat model. J Cardiovasc Electrophysiol 2002; 13: 801-808.